No Detail Found!

Gastric Intestinal Metaplasia: An Intermediate Precancerous Lesion in the Cascade of Gastric Carcinogenesis.

Author(s)
Tayyab Hamid Malik Department of Gastroenterology and Endoscopy Center, First Hospital of Jilin University, Xinmin Street, Changchun-130021, China
Mujtaba Yousef Al Sayahan Norman Bethune Health Science Center, Jilin University, Changchun, China
Hussain Ali Al Ahmed Norman Bethune Health Science Center, Jilin University, Changchun, China
Xu Hong Department of Gastroenterology and Endoscopy Center, First Hospital of Jilin University, Xinmin Street, Changchun-130021, China
Abstract
Gastric intestinal metaplasia, an intermediate lesion in the development of intestinal-type gastric cancer, is observed in the milieu of long standing non-atrophic gastritis and atrophic gastritis. Most patients with intestinal metaplasia remain asymptomatic unless cobalamin deficiency occurs secondary to loss of glands (that produce intrinsic factor and acid). Genetic events that predispose to development of gastric intestinal metaplasia remains an enigma. Mechanisms leading to the progression of atrophy to metaplasia still needs to be comprehensively explored. Many studies in the literature describe a positive effect of typing intestinal metaplasia and concluded that intestinal metaplasia type III carries the highest risk for developing gastric cancer while others refute it. It is well established that Helicobacter pylori infection is the most important factor for the development of chronic gastritis, gastric intestinal metaplasia as well as gastric cancer. Countries with a higher prevalence of Helicobacter pylori infection and gastric cancer also have a high tendency of being prevalent for intestinal metaplasia. However, it remains elusive whether eradication of Helicobacter pylori infection tends to regress gastric intestinal metaplasia or reduce the subsequent risk of cancer development. Putting together, more prospective cohort studies should be designed to identify factors (antioxidants; anti-inflammatory drugs; food therapy) that may contribute in the regression of intestinal metaplasia, when used simultaneously with eradication therapy. Furthermore, molecular markers for evaluation of intestinal metaplasia, and the potential point-of-no-return should be further investigated. Consensus is also required to advocate a timeframe for surveillance of patients with gastric intestinal metaplasia.
Publication Details
Page(s) 166-172
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 27, Issue: 3, Year: 2017

Request the full text from PASTIC

Keywords
Atrophic gastritis. Intestinal metaplasia. Gastric cancer. Endoscopy. Helicobacter pylori
References
CorreaP, 1995.Helicobacter pylori and gastric carcinogenesis,Am J Surg Pathol 19 S37 -43
HuangJQ,SridharS,ChenY,HuntRH, 1998.Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer,Gastroenterology 114 1169 -79
EslickGD,LimLL,BylesJE,XiaHH,TalleyNJ, 1999.Association of Helicobacter pylori infection with gastric carcinoma: A metaanalysis,Am J Gastroenterol 94 2373 -9
1994.4. Infection with Helicobacter pylori,IARC Monogr Eval Carcinog Risks Hum 61 177 -240
SipponenP,KekkiM,HaapakoskiJ,IhamakiT,SiuralaM., 1985.Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross-sectional data,Int J Cancer 35 173 -7
ChoSJ,ChoiIJ,KimCG,KookMC,LeeJY,KimBC, 2010.Risk factors associated with gastric cancer in patients with a duodenal ulcer,Helicobacter 15 516 -23
KimuraK,SatohK,IdoK,TaniguchiY,TakimotoT,TakemotoT., 1996.Gastritis in the Japanese stomach,Scand J Gastroenterol 214 17 -20
YiqiDu,Xiaohua Hou, 2014.Chronic gastritis in China: A national multicenter survey,BMC Gastroenterology 14 21 -
QuachDT,LeHM,HiyamaT,NguyenOT,NguyenTS,UemuraN., 2012.Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia,Helicobacter 18 151 -7
EshmuratovA,NahJC,KimN,LeeHS,LeeHE,LeeBH, 2010.The correlation of endoscopic and histological diagnosis of gastric atrophy,Dig Dis Sci 55 1364 -75
LimJH,KimN,LeeHS,ChoeG,JoSY,ChonI, 2013.Correlation between endoscopic and histological diagnoses of gastric intestinal metaplasia,Gut Liver 7 41 -50
de VriesAC,HaringsmaJ,KuipersEJ, 2007.The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection,Helicobacter 12 1 -15
FilipeMI,MuñozN,MatkoI,KatoI,Pompe-KirnV,JutersekA, 1994.Intestinal metaplasia type and the risk of gastric cancer: A cohort study in Slovenia,Int J Cancer 57 324 -9
ReisCA,DavidL,CorreaP,CarneiroF,de BolósC,GarciaE, 1999.Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression,Cancer Res 59 1003 -7
El-ZimaityHMT,RamchatesinghJ,SaeedMA,GrahamDY, 2001.Gastric intestinal metaplasia: Subtypes and natural history,J Clin Pathol 54 679 -83
KimN,ParkRY,ChoSI,LimSH,LeeKH,LeeW, 2008.Helicobacter pylori infection and development of gastric cancer in Korea: Long-term follow-up,J Clin Gastroenterol 42 448 -54
LiuQ,TehM,ItoK,ShahN,ItoY,YeohKG, 2007.CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer,Mod Pathol 20 1286 -97
CamiloV,BarrosR,SousaS,MagalhãesAM,LopesT,Mário SantosA, 2012.Helicobacter pylori and the BMP pathway regulate CDX2 and SOX2 expression in gastric cells,Carcinogenesis 33 1985 -92
BarrosR,PereiraB,DulucI,AzevedoM,MendesN,CamiloV, 2008.Key elements of the BMP/SMAD pathway colocalize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines,J Pathol 215 411 -20
LiB,LiuHY,GuoSH,SunP,GongFM,JiaBQ, 2015.Microsatellite instability of gastric cancer and precancerous lesions,Int J Clin Exp Med 8 21138 -44
LeungWK,KimJJ,KimJG,GrahamDY,SepulvedaAR, 2000.Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer,Am J Pathol 156 537 -43
KatsoulidisE,MavrommatisE,WoodardJ,ShieldsMA,SassanoA,CarayolN, 2010.Role of interferon alfa inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells,J Biol Chem 285 40333 -41
Companioni NápolesO,TsaoAC,Sanz-AnquelaJM,SalaN,BonetC,PardoML, .SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer,J Gastroenterol 1202-4. -
RodierF,CampisiJ,BhaumikD, 2007.Two faces of p53: Aging and tumor suppression,Nucleic Acids Res 35 7475 -84
WuMS,ShunCT,LeeWC,ChenCJ,WangHP,LeeWJ, 1998.Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer,Br J Cancer 78 971 -3
AnagnostopoulosGK,StefanouD,ArkoumaniE,KaragiannisJ,ParaskevaK,ChalkleyL, 2008.Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions,J Gastroenterol Hepatol 23 626 -31
Zhong-YueXiao,Jiang-TaoSun,She-GanGao,Li-Dong Wang, 2012.Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis,Asian Pacific J Cancer Prev 13 247 -50
DasKM,SakamakiS,VecchiM,DiamondB., 1987.The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: Cellular localization of the antigen using the monoclonal antibody,J Immunol 139 77 -84
MirzaZK,DasKK,SlateJ,MapitigamaRN,AmentaPS,GriffelLH, 2003.Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma,Gut 52 807 -12
BertuccioP,ChatenoudL,LeviF,PraudD,FerlayJ,NegriE, 2009.Recent patterns in gastric cancer : A global overview,Int J Cancer 125 666 -73
YangL, 2006.Incidence and mortality of gastric cancer in China,World J Gastroenterol 12 17 -20
ChenSL,MoJZ,CaoZJ,ChenXU,Shu-Dong Xiao, 2005.Effects of bile reflux on gastric mucosal lesions in patients with dyspepsia or chronic gastritis,World J Gastroenterol 11 2834 -7
LeungWK,EndersKW,WingY,ChanWY,AlexCM,ChanK, 2005.Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients,Cancer Epidemiol Biomarkers Prev 14 12 -
Dias-NetoM,PintalhãoM,FerreiraM,LunetN., 2010.Salt intake and risk of gastric intestinal metaplasia: Systematic review and meta-analysis,Nutr Cancer 62 133 -47
RussoA,MaconiG,SpinelliP,FeliceGD,EboliM,AndreolaS, 2001.Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects,Am J Gastroenterol 96 1402 -8
CompareD,RoccoA,NardoneG, 2010.Risk factors in gastric cancer,Riv Eur Sci Med Farmacol 14 302 -8
PeleteiroB,BastosJ,BarrosH,LunetN., 2008.Systematic review of the prevalence of gastric intestinal metaplasia and its arealevel association with smoking,Gac Sanit 22 236 -47
ChenS,YingL,KongM,ZhangY,LiY., 2013.The prevalence of Helicobacter pylori infection decreases with older age in atrophic gastritis,Gastroenterol Res Pract 494783 -
OlmezS,AslanM,ErtenR,SayarS,BayramI., 2015.The prevalence of gastric intestinal metaplasia and distribution of Helicobacter pylori infection, atrophy, dysplasia, and cancer in its subtypes,Gastroenterol Res Pract 434039 -
LiyaZ,SanrenL,ShigangD,XuebiaoH,ZhuJ,RongliC, 2014.Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: A 10-year follow-up study,Chin Med J 127 8 -
KodamaM,MurakamiK,OkimotoT,AbeT,NakagawaY,MizukamiK, 2012.Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation,Digestion 85 126 -30
KodamaM,MurakamiK,OkimotoT,SatoR,UchidaM,AbeT, 2012.Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication,J Gastroenterol 47 394 -403
ToyokawaT,SuwakiK,MiyakeY,NakatsuM,AndoM., 2010.Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: A long-term prospective cohort study,J Gastroenterol Hepatol 25 544 -7
LahnerE,BordiC,CattaruzzaMS,IannoniC,MilioneM,Delle FaveG, 2005.Long-term follow-up in atrophic body gastritis patients: Atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection,Aliment Pharmacol Ther 22 471 -81
LeyC,MoharA,GuarnerJ, 2004.Helicobacter pylori eradication and gastric preneoplastic conditions: A randomized, double-blind, placebo-controlled trial,Cancer Epidemiol Biomarkers Prev 13 4 -10
ItoM,HarumaK,KamadaT,MiharaM,KimS,KitadaiY, 2002.Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: A 5-year prospective study of patients with atrophic gastritis,Aliment Pharmacol Ther 16 1449 -56
LeeY,JeonYC,KooTY,ChoHS,ByunTJ,KimTY, 2007.Histological changes of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication,Korean J Gastroenterol 50 299 -305
WatariJ,ChenN,AmentaPS,FukuiH,OshimaT,TomitaT, 2014.Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development,World J Gastroenterol 20 5461 -73
TavaF,LuinettiO,GhignaMR,AlvisiC,PeregoM,TrespiE, 2006.Type or extension of intestinal metaplasia and immature/ atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia,Hum Pathol 37 1489 -97
HirotaWK,ZuckermanMJ,AdlerDG,DavilaRE,EganJ,LeightonJA, 2006.ASGE guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract,Gastrointest Endosc 63 570 -80
Dinis-RibeiroM,AreiaM,de VriesAC,Marcos-PintoR,Monteiro-SoaresM,O'ConnorA, 2012.Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED),Endoscopy 44 74 -94
SuganoK,TackJ,KuipersEJ,GrahamDY,El-OmarEM,MiuraS, 2015.,Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64 1353 -67
WatabeH,MitsushimaT,YamajiY,OkamotoM,WadaR,KokuboT, 2005.Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study,Gut 54 764 -8
0

Citations

0

Downloads

68

Views